Clinical trials: Hematological Cancer
Hematologic Neoplasms, Hematopoietic Stem Cell Transplantation
Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT
Graft-versus-Host Disease (GVHD) and relapse, which is mainly due to lack of Graft-versus-Leukemia (GVL), are the most frequent and severe complications of allogeneic hematopoietic stem cell transplantation (allo-HSCT).
- Conditions
- Hematologic Neoplasms, Hematopoietic Stem Cell Transplantation, Graft Vs Host Disease, Recurrence
- Trial name
- NCT03575767
- Testing
- Myeloablative Hematopoietic Stem Cell Transplantation
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Affiliated Hospital to Academy of Military Medical Sciences
Bone Marrow Disease, Hematological Malignancy
The Effect of Music Therapy on Comfort, Pain and Anxiety
Objectives: This study was conducted to determine the effect of music therapy on the pain, anxiety, and comfort levels of patients who underwent bone marrow aspiration and biopsy.
- Trial name
- NCT05895357
- Testing
- Musictherapy
- Where
- Turkey (Türkiye)
- Volunteers
- 66 people
- Sponsor
- Izmir Bakircay University
Haematologic Neoplasm
Characteristics and Outcomes of Patients With Hematological Malignancies
The pattern of hematological malignancies (HMs) in developing countries and developed countries differs. Among the different types of cancers, leukemia, lymphoma, and multiple myeloma appear to have greatly increased in frequency.
- Trial name
- NCT06402175
- Testing
- follow up
- Volunteers
- 100 people
- Sponsor
- Assiut University
Hematological Malignancy, Acute Respiratory Failure
Prognosis of Hematological Cancer Patient Underwent Mechanical Ventillation
This observational cohort aimed to re-evaluate the outcome of hematologic cancer patients admitted to the intensive care unit of Mansoura oncology center through a cohort study as regards their need for mechanical ventilation…
- Conditions
- Hematological Malignancy, Acute Respiratory Failure, Mechanical Ventilation
- Trial name
- NCT02562105
- Testing
- Mechanical ventilation
- Where
- Egypt
- Volunteers
- 50 people
- Sponsor
- Mansoura University
Hematological Malignancy
Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours
The trial is designed as an early exploratory single-centre, open, single-arm clinical trial. The trial is planned to evaluate the safety and efficacy of CAR-T for the treatment of relapsed refractory malignant haematological…
- Trial name
- NCT06238336
- Testing
- CAR-T cell therapy
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Shanxi Bethune Hospital
Pediatric Solid Tumor
A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid Tumor
This study aims to compare and evaluate the predicted values of the participants, and the algorithm predicted values of ANC level reduction periods after high-capacity chemotherapy in pediatric solid tumor patients.
- Trial name
- NCT05024331
- Where
- South Korea
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Samsung Medical Center
Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma
A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies
A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies
- Trial name
- NCT04532203
- Testing
- CAR-T cells, Ommaya Reservoir
- Where
- China
- Volunteers
- 72 people
- Sponsor
- Zhejiang University
B-cell Non Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia
Treatment of Hematological Malignancy With Novel CAR-T Cells.
This is a single arm, open-label, early phase I study, to determine the safety and efficacy of Novel CAR-T cell therapy in Hematological Malignancy treatment.
- Conditions
- B-cell Non Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia, Multiple Myeloma
- Trial name
- NCT04191941
- Testing
- Novel CAR-T
- Where
- China
- Volunteers
- 9 people
- Sponsor
- Timmune Biotech Inc.
AML
Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological Malignancies
Clinical Study on the Safety and Effectiveness of CD38 CAR-T Cells in the Treatment of CD38-positive Hematological Malignancies
- Trial name
- NCT05239689
- Testing
- CD38 CAR T-cells
- Where
- China
- Volunteers
- 36 people
- Sponsor
- Zhejiang University